A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Syndax Pharmaceuticals
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)